Proceeding Report of the Second Vitiligo International Symposium—November 9–10, 2018, Detroit, Michigan, USA.

Boniface (Bordeaux, France) found that perilesional skin in progressive vitiligo patients reveals upregulation of NKG2D when compared to stable vitiligo and control patients. Patients with active vitiligo had significantly higher serum IL-23 levels than controls, whereas stable vitiligo patients did not have a significant difference in IL-23 levels when compared to controls. Vitiligo treatments Results of clinical trials and studies on vitiligo treatments were presented. Lectures were given by vitiligo experts from different countries regarding tissue and cell transfer surgical approaches to vitiligo treatment. [Extracted from the article]